Related Experiment Video
Updated: Jul 12, 2026

10:09
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Brunner's missing 'Aha experience' delayed progress in diabetes research by 200 years
Fritz S Keck1, Leonidas H Duntas
1Westkuestenklinikum Heide, Germany. fkeck@WKK-hei.de
Summary
The 1889 pancreatectomy in dogs revealed the pancreas causes diabetes. Earlier, Johann Conrad Brunner described diabetes symptoms after pancreatectomy but missed the crucial link, delaying diabetes research by 200 years.
Area of Science:
- Endocrinology and Metabolic Diseases
- Surgical History
- Physiology
Background:
- Johann Conrad Brunner's 17th-century pancreatectomy experiments in dogs accurately documented key diabetes symptoms: polyphagia, polyuria, and polydipsia.
- Despite detailed observations, Brunner failed to connect these symptoms to pancreatic function or diabetes mellitus.
- The significance of pancreatic involvement in diabetes remained unrecognized for two centuries following Brunner's work.
Discussion:
- Joseph von Mehring and Oskar Minkowski's 1889 pancreatectomy in dogs definitively established the pancreas's role in diabetes pathogenesis.
- This landmark discovery highlighted the critical link between pancreatic extracts and glucose regulation, paving the way for future research.
- The historical contrast between Brunner's observations and Mehring and Minkowski's conclusion underscores the importance of scientific interpretation and timely discovery.
Key Insights:
- The pancreas is the primary organ responsible for the development of diabetes disease.
- Accurate observation of symptoms (polyphagia, polyuria, polydipsia) is crucial but requires correct interpretation to advance scientific understanding.
- Scientific breakthroughs can be significantly delayed by missed connections between empirical evidence and underlying mechanisms.
Outlook:
- Further research into pancreatic function and its hormonal secretions, like insulin, became a direct consequence of this discovery.
- Understanding the pancreatic origin of diabetes accelerated the development of diagnostic and therapeutic strategies for managing the disease.
- This historical case exemplifies how foundational research, even when incomplete, sets the stage for subsequent critical advancements in medicine.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
